Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

Data as of Oct 20
 +0.91 / +2.93%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It is engaged in the development and commercialization of innovative, life-altering therapies for patients with debilitating and often fatal rare diseases. The company's lead product, lomitapide, is a small molecule, oral therapy to treat severe lipid disorders for an orphan patient population. The company was founded by David I. Scheer and William H. Lewis on February 4, 2005 and is headquartered in Cambridge, MA.

Contact Information

Aegerion Pharmaceuticals, Inc.
101 Main Street
Cambridge Massachusetts 02142-1519
P:(617) 500-7867
Investor Relations:
(617) 242-5028



Other institutional63.09%
Mutual fund holders62.60%
Individual stakeholders37.36%

Top Executives

Marc D. BeerChief Executive Officer & Director
Craig E. FraserChief Operating Officer
Mark J. FitzpatrickChief Financial Officer
Diane L. TribbleChief Scientific Officer
Mark SumerayChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.